These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33023447)

  • 1. The Association between Polygenic Hazard and Markers of Alzheimer's Disease Following Stratification for APOE Genotype.
    De Marco M; Manca R; Kirby J; Hautbergue GM; Blackburn DJ; Wharton SB; Venneri A; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):667-679. PubMed ID: 33023447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociable influences of
    Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
    Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Oveisgharan S; Buchman AS; Yu L; Farfel J; Hachinski V; Gaiteri C; De Jager PL; Schneider JA; Bennett DA
    Neurology; 2018 Jun; 90(24):e2127-e2134. PubMed ID: 29752306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis.
    Sudre CH; Cardoso MJ; Frost C; Barnes J; Barkhof F; Fox N; Ourselin S;
    Neurobiol Aging; 2017 May; 53():67-75. PubMed ID: 28235680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    Psychogeriatrics; 2016 Jan; 16(1):3-11. PubMed ID: 25919635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASSOCIATION BETWEEN APOE-ε
    Mimenza-Alvarado AJ; Suing-Ortega MJ; Tusie-Luna T; Juárez-Cedillo T; Ávila-Funes JA; Aguilar-Navarro SG
    Rev Invest Clin; 2022; 74(2):113-120. PubMed ID: 35354197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic hazard scores in preclinical Alzheimer disease.
    Tan CH; Hyman BT; Tan JJX; Hess CP; Dillon WP; Schellenberg GD; Besser LM; Kukull WA; Kauppi K; McEvoy LK; Andreassen OA; Dale AM; Fan CC; Desikan RS
    Ann Neurol; 2017 Sep; 82(3):484-488. PubMed ID: 28940650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study.
    Ware EB; Faul JD; Mitchell CM; Bakulski KM
    BMC Med Genomics; 2020 Nov; 13(1):164. PubMed ID: 33143703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene-environment interplay between omega-3 supplementation and APOE ε4 provides insights for Alzheimer's disease precise prevention amongst high-genetic-risk population.
    Li L; Xu W; Tan CC; Cao XP; Wei BZ; Dong CW; Tan L;
    Eur J Neurol; 2022 Feb; 29(2):422-431. PubMed ID: 34710256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
    Tan CH; Bonham LW; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Yokoyama JS; Rabinovici GD; Miller BL; Yaffe K; Schellenberg GD; Kauppi K; Holland D; McEvoy LK; Kukull WA; Tosun D; Weiner MW; Sperling RA; Bennett DA; Hyman BT; Andreassen OA; Dale AM; Desikan RS;
    Brain; 2019 Feb; 142(2):460-470. PubMed ID: 30689776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.